U.S., Oct. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07883070) titled 'Anxiety and Depression in Patients With Hematologic Malignancies' on Aug. 02.
Brief Summary: Assessment of Anxiety and Depression Status in Patients with Hematologic Malignancies
Study Start Date: Oct. 20
Study Type: OBSERVATIONAL
Condition:
Hematologic Disease
Intervention:
OTHER: Baseline Anxiety and/or Depression
Anxiety and depression will be assessed using the Hospital Anxiety and Depression Scale (HADS), consisting of two 7-item subscales (HADS-A and HADS-D), each ranging from 0 to 21. Baseline anxiety and/or depression status will be the exposure of interest. Psychological assessments will be repeated at 3, 6, and 12 m...